Thyroid Lesion Found in 43-Year-Old Woman

Poll

A 43-year-old woman presents with a lesion in the thyroid gland. After further assessment a biopsy is performed. What is your diagnosis?

A 43-year-old woman presents with a lesion in the thyroid gland. According to the pathology slide below, what is your diagnosis?

What is your diagnosis?

A. Papillary carcinoma
B. Follicular carcinoma
C. Lymphocytic thyroiditis
D. Medullary carcinoma

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
Ongoing studies in kidney cancer aim to explore determinants of immune-related adverse effects and strategies for mitigating them.
Machine learning-based approaches may play a role in further understanding of how somatic alterations influence responses or resistance to therapy.
Related Content
How Will Gemcitabine Intravesical System Impact BCG-Unresponsive NMIBC?

How Will Gemcitabine Intravesical System Impact BCG-Unresponsive NMIBC?

Ariana Pelosci
September 17th 2025
Article
Experts detailed key advances in myelofibrosis, multiple myeloma, and lymphoma at the Society of Hematologic Oncology 2025 Annual Meeting.

Unraveling Key Blood Cancer Takeaways From the 2025 SOHO Meeting

Francesca Palandri, MD, PhD;Sundar Jagannath, MD;Adam J. Olszewski, MD
September 17th 2025
Podcast
A statistically significant difference was observed between the 2 groups in patients who received second-line therapy.

Cisplatin/Carboplatin Plus Etoposide Yield Similar Real-World Efficacy in ES-SCLC

Tim Cortese
September 17th 2025
Article
A group of community and academic oncologists exchanged ideas on optimizing therapy across different prostate, kidney, and bladder cancer populations.

Elevating Community Oncology Care: Insights From World GU 2025

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Sam S. Chang MD, MBA;Jeff Yorio, MD
September 17th 2025
Podcast
Understanding Palliative and End-Of-Life Care in Oncology

Understanding Palliative and End-Of-Life Care in Oncology

Julie M. Vose, MD, MBA
September 17th 2025
Article
Data from the IDeate-Lung01 trial support the potential role that ifinatamab deruxtecan may play in the management of extensive-stage small cell lung cancer.

I-DXd Shows “Impressive” Responses in Extensive-Stage SCLC

Russ Conroy
September 17th 2025
Article